| UniProt ID | CTNA1_MOUSE | |
|---|---|---|
| UniProt AC | P26231 | |
| Protein Name | Catenin alpha-1 | |
| Gene Name | Ctnna1 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 906 | |
| Subcellular Localization |
Cytoplasm, cytoskeleton. Cell junction, adherens junction. Cell membrane Peripheral membrane protein Cytoplasmic side. Cell junction. Found at cell-cell boundaries and probably at cell-matrix boundaries. |
|
| Protein Description | Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation.. | |
| Protein Sequence | MTAVHAGNINFKWDPKSLEIRTLAVERLLEPLVTQVTTLVNTNSKGPSNKKRGRSKKAHVLAASVEQATENFLEKGDKIAKESQFLKEELVVAVEDVRKQGDLMKSAAGEFADDPCSSVKRGNMVRAARALLSAVTRLLILADMADVYKLLVQLKVVEDGILKLRNAGNEQDLGIQYKALKPEVDKLNIMAAKRQQELKDVGNRDQMAAARGILQKNVPILYTASQACLQHPDVAAYKANRDLIYKQLQQAVTGISNAAQATASDDAAQHQGGSGGELAYALNNFDKQIIVDPLSFSEERFRPSLEERLESIISGAALMADSSCTRDDRRERIVAECNAVRQALQDLLSEYMGNAGRKERSDALNSAIDKMTKKTRDLRRQLRKAVMDHVSDSFLETNVPLLVLIEAAKNGNEKEVKEYAQVFREHANKLIEVANLACSISNNEEGVKLVRMSASQLEALCPQVINAALALAAKPQSKLAQENMDLFKEQWEKQVRVLTDAVDDITSIDDFLAVSENHILEDVNKCVIALQEKDVDGLDRTAGAIRGRAARVIHVVTSEMDNYEPGVYTEKVLEATKLLSNTVMPRFTEQVEAAVEALSSDPAQPMDENEFIDASRLVYDGIRDIRKAVLMIRTPEELDDSDFETEDFDVRSRTSVQTEDDQLIAGQSARAIMAQLPQEQKAKIAEQVASFQEEKSKLDAEVSKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVISAAKKIAEAGSRMDKLGRTIADHCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELVVSGVDSAMSLIQAAKNLMNAVVQTVKASYVASTKYQKSQGMASLNLPAVSWKMKAPEKKPLVKREKQDETQTKIKRASQKKHVNPVQALSEFKAMDSI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MTAVHAGNI ------CCCEECCCC | 37.07 | - | |
| 2 | Phosphorylation | ------MTAVHAGNI ------CCCEECCCC | 37.07 | 28576409 | |
| 12 | Ubiquitination | HAGNINFKWDPKSLE ECCCCCCCCCCCCHH | 46.31 | 22790023 | |
| 16 | Ubiquitination | INFKWDPKSLEIRTL CCCCCCCCCHHHHHH | 66.26 | 22790023 | |
| 34 | Phosphorylation | RLLEPLVTQVTTLVN HHHHHHHHHHHHHHC | 25.63 | 27717184 | |
| 37 | Phosphorylation | EPLVTQVTTLVNTNS HHHHHHHHHHHCCCC | 12.47 | 27717184 | |
| 38 | Phosphorylation | PLVTQVTTLVNTNSK HHHHHHHHHHCCCCC | 29.83 | 27717184 | |
| 42 | Phosphorylation | QVTTLVNTNSKGPSN HHHHHHCCCCCCCCC | 33.13 | 29514104 | |
| 44 | Phosphorylation | TTLVNTNSKGPSNKK HHHHCCCCCCCCCCC | 36.63 | 28978645 | |
| 45 | Ubiquitination | TLVNTNSKGPSNKKR HHHCCCCCCCCCCCC | 76.53 | 22790023 | |
| 48 | Phosphorylation | NTNSKGPSNKKRGRS CCCCCCCCCCCCCCC | 70.70 | 29514104 | |
| 50 | Ubiquitination | NSKGPSNKKRGRSKK CCCCCCCCCCCCCCH | 48.46 | - | |
| 57 | Ubiquitination | KKRGRSKKAHVLAAS CCCCCCCHHHHHHHH | 45.00 | 22790023 | |
| 75 | Ubiquitination | ATENFLEKGDKIAKE HHHHHHHHHHHHHHH | 74.65 | 22790023 | |
| 81 | Ubiquitination | EKGDKIAKESQFLKE HHHHHHHHHHHHHHH | 62.46 | 22790023 | |
| 116 | S-palmitoylation | GEFADDPCSSVKRGN CCCCCCCCHHHHHHH | 6.44 | 28526873 | |
| 117 | Phosphorylation | EFADDPCSSVKRGNM CCCCCCCHHHHHHHH | 43.48 | 25338131 | |
| 118 | Phosphorylation | FADDPCSSVKRGNMV CCCCCCHHHHHHHHH | 38.07 | 25195567 | |
| 163 | Ubiquitination | VVEDGILKLRNAGNE CCCCCEEEECCCCCC | 43.40 | 22790023 | |
| 177 | Phosphorylation | EQDLGIQYKALKPEV CCCCCCCHHHHCHHH | 9.05 | 25619855 | |
| 178 | Ubiquitination | QDLGIQYKALKPEVD CCCCCCHHHHCHHHH | 30.76 | 22790023 | |
| 181 | Ubiquitination | GIQYKALKPEVDKLN CCCHHHHCHHHHHHH | 43.95 | 22790023 | |
| 186 | Acetylation | ALKPEVDKLNIMAAK HHCHHHHHHHHHHHH | 48.92 | 23864654 | |
| 193 | Acetylation | KLNIMAAKRQQELKD HHHHHHHHHHHHHHC | 41.00 | 23236377 | |
| 193 | Ubiquitination | KLNIMAAKRQQELKD HHHHHHHHHHHHHHC | 41.00 | 22790023 | |
| 216 | Ubiquitination | AARGILQKNVPILYT HHHHHHHHCCCEEEE | 57.37 | 22790023 | |
| 225 | Phosphorylation | VPILYTASQACLQHP CCEEEECCHHHHHCC | 15.54 | 30352176 | |
| 245 | Phosphorylation | KANRDLIYKQLQQAV HHCHHHHHHHHHHHH | 10.44 | 29514104 | |
| 264 | Phosphorylation | NAAQATASDDAAQHQ HHHHHHCCCHHHHHC | 31.50 | 30352176 | |
| 274 | Phosphorylation | AAQHQGGSGGELAYA HHHHCCCCHHHHHHH | 50.91 | 30352176 | |
| 280 | Phosphorylation | GSGGELAYALNNFDK CCHHHHHHHHCCCCC | 25.01 | 26824392 | |
| 295 | Phosphorylation | QIIVDPLSFSEERFR CEEECCCCCCHHHHC | 31.92 | 30352176 | |
| 297 | Phosphorylation | IVDPLSFSEERFRPS EECCCCCCHHHHCCC | 34.86 | 30352176 | |
| 304 | Phosphorylation | SEERFRPSLEERLES CHHHHCCCHHHHHHH | 44.12 | 22802335 | |
| 323 | Phosphorylation | AALMADSSCTRDDRR HHHHCCCCCCCCHHH | 21.76 | 29899451 | |
| 337 | Glutathionylation | RERIVAECNAVRQAL HHHHHHHHHHHHHHH | 2.60 | 24333276 | |
| 391 | Phosphorylation | KAVMDHVSDSFLETN HHHHHHCCHHHHHCC | 24.90 | 23984901 | |
| 393 | Phosphorylation | VMDHVSDSFLETNVP HHHHCCHHHHHCCCC | 24.99 | 23984901 | |
| 397 | Phosphorylation | VSDSFLETNVPLLVL CCHHHHHCCCCEEHH | 43.60 | 23984901 | |
| 417 | Ubiquitination | NGNEKEVKEYAQVFR CCCHHHHHHHHHHHH | 46.21 | 22790023 | |
| 419 | Phosphorylation | NEKEVKEYAQVFREH CHHHHHHHHHHHHHH | 9.16 | 22499769 | |
| 438 | Glutathionylation | IEVANLACSISNNEE HHHHHHHHHCCCCHH | 4.12 | 24333276 | |
| 439 | Phosphorylation | EVANLACSISNNEEG HHHHHHHHCCCCHHH | 24.36 | 26824392 | |
| 453 | Phosphorylation | GVKLVRMSASQLEAL HHEEEEECHHHHHHH | 17.76 | 26160508 | |
| 455 | Phosphorylation | KLVRMSASQLEALCP EEEEECHHHHHHHHH | 28.17 | 26160508 | |
| 461 | Glutathionylation | ASQLEALCPQVINAA HHHHHHHHHHHHHHH | 2.60 | 24333276 | |
| 478 | Ubiquitination | LAAKPQSKLAQENMD HHHCCHHHHHHHCHH | 42.46 | 22790023 | |
| 499 | Phosphorylation | EKQVRVLTDAVDDIT HHHHHHHHHCCCCCC | 21.03 | 26239621 | |
| 506 | Phosphorylation | TDAVDDITSIDDFLA HHCCCCCCCHHHHHH | 26.99 | 23984901 | |
| 507 | Phosphorylation | DAVDDITSIDDFLAV HCCCCCCCHHHHHHH | 25.10 | 26824392 | |
| 515 | Phosphorylation | IDDFLAVSENHILED HHHHHHHCCHHHHHH | 27.37 | 26370283 | |
| 571 | Ubiquitination | EPGVYTEKVLEATKL CCCCCHHHHHHHHHH | 44.30 | 22790023 | |
| 576 | Phosphorylation | TEKVLEATKLLSNTV HHHHHHHHHHHCCCC | 16.92 | 28059163 | |
| 577 | Ubiquitination | EKVLEATKLLSNTVM HHHHHHHHHHCCCCC | 55.25 | 22790023 | |
| 619 | Phosphorylation | IDASRLVYDGIRDIR CCHHHHHHHHHHHHH | 17.03 | 25263469 | |
| 634 | Phosphorylation | KAVLMIRTPEELDDS HHHHCCCCHHHCCCC | 24.91 | 25521595 | |
| 641 | Phosphorylation | TPEELDDSDFETEDF CHHHCCCCCCCCCCC | 43.81 | 27087446 | |
| 645 | Phosphorylation | LDDSDFETEDFDVRS CCCCCCCCCCCCCCC | 40.63 | 24925903 | |
| 652 | Phosphorylation | TEDFDVRSRTSVQTE CCCCCCCCCCCEECC | 39.49 | 27087446 | |
| 654 | Phosphorylation | DFDVRSRTSVQTEDD CCCCCCCCCEECCCC | 34.20 | 27087446 | |
| 655 | Phosphorylation | FDVRSRTSVQTEDDQ CCCCCCCCEECCCCC | 15.89 | 27087446 | |
| 658 | Phosphorylation | RSRTSVQTEDDQLIA CCCCCEECCCCCCCC | 38.95 | 24925903 | |
| 668 | Phosphorylation | DQLIAGQSARAIMAQ CCCCCHHHHHHHHHC | 20.85 | 25619855 | |
| 681 | Ubiquitination | AQLPQEQKAKIAEQV HCCCHHHHHHHHHHH | 51.39 | 22790023 | |
| 683 | Ubiquitination | LPQEQKAKIAEQVAS CCHHHHHHHHHHHHH | 49.86 | 22790023 | |
| 690 | Phosphorylation | KIAEQVASFQEEKSK HHHHHHHHHHHHHHH | 28.71 | 30352176 | |
| 695 | Ubiquitination | VASFQEEKSKLDAEV HHHHHHHHHHHHHHH | 52.73 | 22790023 | |
| 695 | Acetylation | VASFQEEKSKLDAEV HHHHHHHHHHHHHHH | 52.73 | 23236377 | |
| 697 | Ubiquitination | SFQEEKSKLDAEVSK HHHHHHHHHHHHHHH | 62.55 | 22790023 | |
| 704 | Ubiquitination | KLDAEVSKWDDSGND HHHHHHHHCCCCCCH | 60.87 | 22790023 | |
| 720 | S-palmitoylation | IVLAKQMCMIMMEMT HHHHHHHHHHHHHHC | 1.22 | 28680068 | |
| 737 | Ubiquitination | TRGKGPLKNTSDVIS CCCCCCCCCHHHHHH | 62.40 | 22790023 | |
| 747 | Malonylation | SDVISAAKKIAEAGS HHHHHHHHHHHHHHH | 44.41 | 26320211 | |
| 747 | Succinylation | SDVISAAKKIAEAGS HHHHHHHHHHHHHHH | 44.41 | 23954790 | |
| 779 | Phosphorylation | CKQDLLAYLQRIALY HHHHHHHHHHHHHHH | 11.88 | 22668510 | |
| 786 | Phosphorylation | YLQRIALYCHQLNIC HHHHHHHHHHHHCCH | 4.47 | 22668510 | |
| 797 | Ubiquitination | LNICSKVKAEVQNLG HCCHHHHHHHHHHCC | 42.43 | 22790023 | |
| 842 | Ubiquitination | ASYVASTKYQKSQGM HHHHHCCCCCCCCCC | 43.09 | - | |
| 842 | Acetylation | ASYVASTKYQKSQGM HHHHHCCCCCCCCCC | 43.09 | 22647165 | |
| 842 | Malonylation | ASYVASTKYQKSQGM HHHHHCCCCCCCCCC | 43.09 | 26320211 | |
| 845 | Ubiquitination | VASTKYQKSQGMASL HHCCCCCCCCCCCCC | 41.47 | 22790023 | |
| 851 | Phosphorylation | QKSQGMASLNLPAVS CCCCCCCCCCCCHHC | 14.65 | - | |
| 858 | Phosphorylation | SLNLPAVSWKMKAPE CCCCCHHCCCCCCCC | 24.08 | - | |
| 860 | Ubiquitination | NLPAVSWKMKAPEKK CCCHHCCCCCCCCCC | 24.02 | 22790023 | |
| 886 | Phosphorylation | QTKIKRASQKKHVNP HHHHHHHHHCCCCCH | 46.71 | - | |
| 898 | Phosphorylation | VNPVQALSEFKAMDS CCHHHHHHHHHHHCC | 43.96 | 19367708 | |
| 905 | Phosphorylation | SEFKAMDSI------ HHHHHHCCC------ | 19.67 | 27357545 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CTNA1_MOUSE !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CTNA1_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CTNA1_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CTNB1_MOUSE | Ctnnb1 | physical | 12695331 | |
| FMN1_MOUSE | Fmn1 | physical | 14647292 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY. | |
| "Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY. | |
| "Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641 AND SER-652, ANDMASS SPECTROMETRY. | |
| "Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-654; SER-655 ANDTHR-658, AND MASS SPECTROMETRY. | |
| "Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY. | |
| "Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641, AND MASSSPECTROMETRY. | |
| "Proteomic analysis of in vivo phosphorylated synaptic proteins."; Collins M.O., Yu L., Coba M.P., Husi H., Campuzano I.,Blackstock W.P., Choudhary J.S., Grant S.G.; J. Biol. Chem. 280:5972-5982(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-652 AND SER-655, ANDMASS SPECTROMETRY. | |
| "Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; THR-654 ANDTHR-658, AND MASS SPECTROMETRY. | |